BRIEF-Joint Statement From Moderna, Takeda On Deaths Of Two Individuals Who Recently Received Moderna COVID-19 Vaccine

Reuters2021-08-28

Aug 28 (Reuters) - Moderna Inc :

* JOINT STATEMENT FROM MODERNA AND TAKEDA

* MODERNA-TAKEDA, MODERNA NOTIFIED ON AUG 28 JST, OF DEATHS OF 2 INDIVIDUALS WHO RECEIVED MODERNA COVID-19 VACCINE FOR INTRAMUSCULAR INJECTION IN JAPAN

* MODERNA - AT THIS TIME, DO NOT HAVE ANY EVIDENCE THAT THESE DEATHS ARE CAUSED BY THE MODERNA COVID-19 VACCINE

* MODERNA - TAKEDA AND MODERNA ARE WORKING WITH MINISTRY OF HEALTH, LABOUR AND WELFARE (MHLW) TO INVESTIGATE TWO DEATHS

* MODERNA- ON AUGUST 26 JST, TAKEDA ANNOUNCED DECISION TO SUSPEND USE OF THREE LOTS OF MODERNA’S COVID-19 VACCINE IN JAPAN

* MODERNA- THE SUSPENSION WAS IN ALIGNMENT WITH MHLW FOLLOWING REPORTS FROM VACCINATION SITES OF A FOREIGN SUBSTANCE FOUND IN VIALS

* MODERNA- TO DATE, HAVE NO PRODUCT QUALITY COMPLAINTS RELATED TO PARTICULATE MATTER IN THE LOT RELATED TO UNFORTUNATE PASSING OF THE TWO INDIVIDUALS

* MODERNA-TAKEDA REQUESTED MODERNA,MODERNA’S EUROPEAN CONTRACT MANUFACTURING ORGANIZATION,CONDUCT INVESTIGATION TO DETERMINE NATURE OF FOREIGN SUBSTANCE

* MODERNA- AWARE OF UNOFFICIAL REPORTS THAT HAVE PROVIDED INITIAL INDICATION OF THE TYPE OF PARTICLE MATTER IN THE VIALS

* MODERNA-IN PROCESS OF CONDUCTING INVESTIGATION, VIALS HAVE BEEN SENT TO QUALIFIED LAB FOR ANALYSIS;INITIAL FINDINGS WILL BE AVAILABLE EARLY NEXT WEEK

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

BWMoxx
2021-08-28
BWMoxx
Oh no

Leave a comment

1

3

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2162768040?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-28 18:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2162768040","market":"us","top_or_hot":-1,"title":"BRIEF-Joint Statement From Moderna, Takeda On Deaths Of Two Individuals Who Recently Received Moderna COVID-19 Vaccine","media":"Reuters","content":"<html><body><p>Aug 28 (Reuters) - Moderna Inc   :</p><p>   * JOINT STATEMENT FROM MODERNA AND TAKEDA</p><p>   * MODERNA-TAKEDA, MODERNA NOTIFIED ON AUG 28 JST, OF DEATHS OF 2 INDIVIDUALS WHO RECEIVED MODERNA COVID-19 VACCINE FOR INTRAMUSCULAR INJECTION IN JAPAN</p><p>   * MODERNA - AT THIS TIME, DO NOT HAVE ANY EVIDENCE THAT THESE DEATHS ARE CAUSED BY THE MODERNA COVID-19 VACCINE</p><p>   * MODERNA - TAKEDA AND MODERNA ARE WORKING WITH MINISTRY OF HEALTH, LABOUR AND WELFARE (MHLW) TO INVESTIGATE TWO DEATHS</p><p>   * MODERNA- ON AUGUST 26 JST, TAKEDA ANNOUNCED DECISION TO SUSPEND USE OF THREE LOTS OF MODERNA’S COVID-19 VACCINE IN JAPAN</p><p>   * MODERNA- THE SUSPENSION WAS IN ALIGNMENT WITH MHLW FOLLOWING REPORTS FROM VACCINATION SITES OF A FOREIGN SUBSTANCE FOUND IN VIALS</p><p>   * MODERNA- TO DATE, HAVE NO PRODUCT QUALITY COMPLAINTS RELATED TO PARTICULATE MATTER IN THE LOT RELATED TO UNFORTUNATE PASSING OF THE TWO INDIVIDUALS</p><p>   * MODERNA-TAKEDA REQUESTED MODERNA,MODERNA’S EUROPEAN CONTRACT MANUFACTURING ORGANIZATION,CONDUCT INVESTIGATION TO DETERMINE NATURE OF FOREIGN SUBSTANCE</p><p>   * MODERNA- AWARE OF UNOFFICIAL REPORTS THAT HAVE PROVIDED INITIAL INDICATION OF THE TYPE OF PARTICLE MATTER IN THE VIALS</p><p>   * MODERNA-IN PROCESS OF CONDUCTING INVESTIGATION, VIALS HAVE BEEN SENT TO QUALIFIED LAB FOR ANALYSIS;INITIAL FINDINGS WILL BE AVAILABLE EARLY NEXT WEEK</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Joint Statement From Moderna, Takeda On Deaths Of Two Individuals Who Recently Received Moderna COVID-19 Vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Joint Statement From Moderna, Takeda On Deaths Of Two Individuals Who Recently Received Moderna COVID-19 Vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-28 18:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Aug 28 (Reuters) - Moderna Inc   :</p><p>   * JOINT STATEMENT FROM MODERNA AND TAKEDA</p><p>   * MODERNA-TAKEDA, MODERNA NOTIFIED ON AUG 28 JST, OF DEATHS OF 2 INDIVIDUALS WHO RECEIVED MODERNA COVID-19 VACCINE FOR INTRAMUSCULAR INJECTION IN JAPAN</p><p>   * MODERNA - AT THIS TIME, DO NOT HAVE ANY EVIDENCE THAT THESE DEATHS ARE CAUSED BY THE MODERNA COVID-19 VACCINE</p><p>   * MODERNA - TAKEDA AND MODERNA ARE WORKING WITH MINISTRY OF HEALTH, LABOUR AND WELFARE (MHLW) TO INVESTIGATE TWO DEATHS</p><p>   * MODERNA- ON AUGUST 26 JST, TAKEDA ANNOUNCED DECISION TO SUSPEND USE OF THREE LOTS OF MODERNA’S COVID-19 VACCINE IN JAPAN</p><p>   * MODERNA- THE SUSPENSION WAS IN ALIGNMENT WITH MHLW FOLLOWING REPORTS FROM VACCINATION SITES OF A FOREIGN SUBSTANCE FOUND IN VIALS</p><p>   * MODERNA- TO DATE, HAVE NO PRODUCT QUALITY COMPLAINTS RELATED TO PARTICULATE MATTER IN THE LOT RELATED TO UNFORTUNATE PASSING OF THE TWO INDIVIDUALS</p><p>   * MODERNA-TAKEDA REQUESTED MODERNA,MODERNA’S EUROPEAN CONTRACT MANUFACTURING ORGANIZATION,CONDUCT INVESTIGATION TO DETERMINE NATURE OF FOREIGN SUBSTANCE</p><p>   * MODERNA- AWARE OF UNOFFICIAL REPORTS THAT HAVE PROVIDED INITIAL INDICATION OF THE TYPE OF PARTICLE MATTER IN THE VIALS</p><p>   * MODERNA-IN PROCESS OF CONDUCTING INVESTIGATION, VIALS HAVE BEEN SENT TO QUALIFIED LAB FOR ANALYSIS;INITIAL FINDINGS WILL BE AVAILABLE EARLY NEXT WEEK</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2162768040","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2162768040","pubTimestamp":1630146894,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Aug 28 (Reuters) - Moderna Inc   :   * JOINT STATEMENT FROM MODERNA AND TAKEDA   * MODERNA-TAKEDA, M","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"简报--武田莫德纳关于最近接受莫德纳新冠肺炎疫苗的两人死亡的联合声明","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"Aug 28 (Reuters) - Moderna Inc   :   * JOINT STATEMENT FROM MODERNA AND TAKEDA   * MODERNA-TAKEDA, MODERNA NOTIFIED ON AUG 28 JST, OF DEATHS OF 2 INDIVIDUALS WHO RECEIVED MODERNA COVID-19 VACCINE FOR INTRAMUSCULAR INJECTION IN JAPAN   * MODERNA - AT THIS TIME, DO NOT HAVE ANY EVIDENCE THAT THESE DEATHS ARE CAUSED BY THE MODERNA COVID-19 VACCINE   * MODERNA - TAKEDA AND MODERNA ARE WORKING WITH MINISTRY OF HEALTH, LABOUR AND WELFARE (MHLW) TO INVESTIGATE TWO DEATHS   * MODERNA- ON AUGUST 26 JST, TAKEDA ANNOUNCED DECISION TO SUSPEND USE OF THREE LOTS OF MODERNA’S COVID-19 VACCINE IN JAPAN   * MODERNA- THE SUSPENSION WAS IN ALIGNMENT WITH MHLW FOLLOWING REPORTS FROM VACCINATION SITES OF A FOREIGN SUBSTANCE FOUND IN VIALS   * MODERNA- TO DATE, HAVE NO PRODUCT QUALITY COMPLAINTS RELATED TO PARTICULATE MATTER IN THE LOT RELATED TO UNFORTUNATE PASSING OF THE TWO INDIVIDUALS   * MODERNA-TAKEDA REQUESTED MODERNA,MODERNA’S EUROPEAN CONTRACT MANUFACTURING ORGANIZATION,CONDUCT INVESTIGATION TO DETERMINE NATURE OF FOREIGN SUBSTANCE   * MODERNA- AWARE OF UNOFFICIAL REPORTS THAT HAVE PROVIDED INITIAL INDICATION OF THE TYPE OF PARTICLE MATTER IN THE VIALS   * MODERNA-IN PROCESS OF CONDUCTING INVESTIGATION, VIALS HAVE BEEN SENT TO QUALIFIED LAB FOR ANALYSIS;INITIAL FINDINGS WILL BE AVAILABLE EARLY NEXT WEEKSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":813169650,"gmtCreate":1630152850670,"gmtModify":1676530235434,"author":{"id":"4088487325195880","authorId":"4088487325195880","name":"BWMoxx","avatar":"https://static.tigerbbs.com/694294fee8427f7a37139676fc8accaa","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"4088487325195880","authorIdStr":"4088487325195880"},"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813169650","repostId":2162768040,"repostType":2,"repost":{"id":"2162768040","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630146894,"share":"https://ttm.financial/m/news/2162768040?lang=en_US&edition=fundamental","pubTime":"2021-08-28 18:34","market":"us","language":"en","title":"BRIEF-Joint Statement From Moderna, Takeda On Deaths Of Two Individuals Who Recently Received Moderna COVID-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2162768040","media":"Reuters","summary":"Aug 28 (Reuters) - Moderna Inc   :   * JOINT STATEMENT FROM MODERNA AND TAKEDA   * MODERNA-TAKEDA, M","content":"<html><body><p>Aug 28 (Reuters) - Moderna Inc   :</p><p>   * JOINT STATEMENT FROM MODERNA AND TAKEDA</p><p>   * MODERNA-TAKEDA, MODERNA NOTIFIED ON AUG 28 JST, OF DEATHS OF 2 INDIVIDUALS WHO RECEIVED MODERNA COVID-19 VACCINE FOR INTRAMUSCULAR INJECTION IN JAPAN</p><p>   * MODERNA - AT THIS TIME, DO NOT HAVE ANY EVIDENCE THAT THESE DEATHS ARE CAUSED BY THE MODERNA COVID-19 VACCINE</p><p>   * MODERNA - TAKEDA AND MODERNA ARE WORKING WITH MINISTRY OF HEALTH, LABOUR AND WELFARE (MHLW) TO INVESTIGATE TWO DEATHS</p><p>   * MODERNA- ON AUGUST 26 JST, TAKEDA ANNOUNCED DECISION TO SUSPEND USE OF THREE LOTS OF MODERNA’S COVID-19 VACCINE IN JAPAN</p><p>   * MODERNA- THE SUSPENSION WAS IN ALIGNMENT WITH MHLW FOLLOWING REPORTS FROM VACCINATION SITES OF A FOREIGN SUBSTANCE FOUND IN VIALS</p><p>   * MODERNA- TO DATE, HAVE NO PRODUCT QUALITY COMPLAINTS RELATED TO PARTICULATE MATTER IN THE LOT RELATED TO UNFORTUNATE PASSING OF THE TWO INDIVIDUALS</p><p>   * MODERNA-TAKEDA REQUESTED MODERNA,MODERNA’S EUROPEAN CONTRACT MANUFACTURING ORGANIZATION,CONDUCT INVESTIGATION TO DETERMINE NATURE OF FOREIGN SUBSTANCE</p><p>   * MODERNA- AWARE OF UNOFFICIAL REPORTS THAT HAVE PROVIDED INITIAL INDICATION OF THE TYPE OF PARTICLE MATTER IN THE VIALS</p><p>   * MODERNA-IN PROCESS OF CONDUCTING INVESTIGATION, VIALS HAVE BEEN SENT TO QUALIFIED LAB FOR ANALYSIS;INITIAL FINDINGS WILL BE AVAILABLE EARLY NEXT WEEK</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Joint Statement From Moderna, Takeda On Deaths Of Two Individuals Who Recently Received Moderna COVID-19 Vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Joint Statement From Moderna, Takeda On Deaths Of Two Individuals Who Recently Received Moderna COVID-19 Vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-28 18:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Aug 28 (Reuters) - Moderna Inc   :</p><p>   * JOINT STATEMENT FROM MODERNA AND TAKEDA</p><p>   * MODERNA-TAKEDA, MODERNA NOTIFIED ON AUG 28 JST, OF DEATHS OF 2 INDIVIDUALS WHO RECEIVED MODERNA COVID-19 VACCINE FOR INTRAMUSCULAR INJECTION IN JAPAN</p><p>   * MODERNA - AT THIS TIME, DO NOT HAVE ANY EVIDENCE THAT THESE DEATHS ARE CAUSED BY THE MODERNA COVID-19 VACCINE</p><p>   * MODERNA - TAKEDA AND MODERNA ARE WORKING WITH MINISTRY OF HEALTH, LABOUR AND WELFARE (MHLW) TO INVESTIGATE TWO DEATHS</p><p>   * MODERNA- ON AUGUST 26 JST, TAKEDA ANNOUNCED DECISION TO SUSPEND USE OF THREE LOTS OF MODERNA’S COVID-19 VACCINE IN JAPAN</p><p>   * MODERNA- THE SUSPENSION WAS IN ALIGNMENT WITH MHLW FOLLOWING REPORTS FROM VACCINATION SITES OF A FOREIGN SUBSTANCE FOUND IN VIALS</p><p>   * MODERNA- TO DATE, HAVE NO PRODUCT QUALITY COMPLAINTS RELATED TO PARTICULATE MATTER IN THE LOT RELATED TO UNFORTUNATE PASSING OF THE TWO INDIVIDUALS</p><p>   * MODERNA-TAKEDA REQUESTED MODERNA,MODERNA’S EUROPEAN CONTRACT MANUFACTURING ORGANIZATION,CONDUCT INVESTIGATION TO DETERMINE NATURE OF FOREIGN SUBSTANCE</p><p>   * MODERNA- AWARE OF UNOFFICIAL REPORTS THAT HAVE PROVIDED INITIAL INDICATION OF THE TYPE OF PARTICLE MATTER IN THE VIALS</p><p>   * MODERNA-IN PROCESS OF CONDUCTING INVESTIGATION, VIALS HAVE BEEN SENT TO QUALIFIED LAB FOR ANALYSIS;INITIAL FINDINGS WILL BE AVAILABLE EARLY NEXT WEEK</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162768040","content_text":"Aug 28 (Reuters) - Moderna Inc   :   * JOINT STATEMENT FROM MODERNA AND TAKEDA   * MODERNA-TAKEDA, MODERNA NOTIFIED ON AUG 28 JST, OF DEATHS OF 2 INDIVIDUALS WHO RECEIVED MODERNA COVID-19 VACCINE FOR INTRAMUSCULAR INJECTION IN JAPAN   * MODERNA - AT THIS TIME, DO NOT HAVE ANY EVIDENCE THAT THESE DEATHS ARE CAUSED BY THE MODERNA COVID-19 VACCINE   * MODERNA - TAKEDA AND MODERNA ARE WORKING WITH MINISTRY OF HEALTH, LABOUR AND WELFARE (MHLW) TO INVESTIGATE TWO DEATHS   * MODERNA- ON AUGUST 26 JST, TAKEDA ANNOUNCED DECISION TO SUSPEND USE OF THREE LOTS OF MODERNA’S COVID-19 VACCINE IN JAPAN   * MODERNA- THE SUSPENSION WAS IN ALIGNMENT WITH MHLW FOLLOWING REPORTS FROM VACCINATION SITES OF A FOREIGN SUBSTANCE FOUND IN VIALS   * MODERNA- TO DATE, HAVE NO PRODUCT QUALITY COMPLAINTS RELATED TO PARTICULATE MATTER IN THE LOT RELATED TO UNFORTUNATE PASSING OF THE TWO INDIVIDUALS   * MODERNA-TAKEDA REQUESTED MODERNA,MODERNA’S EUROPEAN CONTRACT MANUFACTURING ORGANIZATION,CONDUCT INVESTIGATION TO DETERMINE NATURE OF FOREIGN SUBSTANCE   * MODERNA- AWARE OF UNOFFICIAL REPORTS THAT HAVE PROVIDED INITIAL INDICATION OF THE TYPE OF PARTICLE MATTER IN THE VIALS   * MODERNA-IN PROCESS OF CONDUCTING INVESTIGATION, VIALS HAVE BEEN SENT TO QUALIFIED LAB FOR ANALYSIS;INITIAL FINDINGS WILL BE AVAILABLE EARLY NEXT WEEKSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2162768040","isCrawlerRequest":true}